Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06641206
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-11
Brief Title:
Intra-Articular Dexmedetomidine A Treatment for Chronic Knee Pain
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Intra-articular Dexmedetomidine for Treatment of Chronic Knee Pain A Prospective Case-Control Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chronic knee osteoarthritis KOA is a painful condition with limited treatment options Non-pharmacological approaches often fall short leading to decreased quality of life Ozone therapy a simple and affordable treatment has shown promise for pain relief Dexmedetomidine DEX a sedative and analgesic has been used successfully as an adjuvant to anesthesia and local anesthetics Given its potential for pain management exploring DEX as a treatment for KOA could offer a new and promising approach
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None